Alternate Text DC Chemicals' products qualify for U.S. tariff exemptions. We guarantee no price increases due to customs duties and maintain stable supply, continuing to deliver reliable research solutions to our American clients.

PF-06291874(glucagon receptor antagonists-4)

  Cat. No.:  DC10003   Featured
Chemical Structure
1393124-08-7
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
glucagon receptor antagonists-4 is a highly potent glucagon receptor antagonist.
Cas No.: 1393124-08-7
Chemical Name: Glucagon receptor antagonists-4
Synonyms: glucagon receptor antagonists-4;N-[4-[(1S)-1-[3,5-Dimethyl-4-[4-(trifluoromethyl)-1H-pyrazol-1-yl]phenoxy]butyl]benzoyl]--alanine;PF-06291874;CGY4I8F278;(S)-3-(4-(1-(3,5-dimethyl-4-(4-(trifluoromethyl)-1H-pyrazol-1-yl)phenoxy)butyl)benzamido)propanoic acid;BDBM50433577;DB15065;PF06291874; Glucagon receptor antagonists-4;3-[[4-[(1S)-1-[3,5-dimethyl-4-[4-(trifluoromethyl)pyrazol-1-yl]phenoxy]butyl]benzoyl]amino]propanoic acid;beta-Alanine, N-(4-((1S
SMILES: FC(C1C([H])=NN(C=1[H])C1C(C([H])([H])[H])=C([H])C(=C([H])C=1C([H])([H])[H])O[C@]([H])(C1C([H])=C([H])C(C(N([H])C([H])([H])C([H])([H])C(=O)O[H])=O)=C([H])C=1[H])C([H])([H])C([H])([H])C([H])([H])[H])(F)F
Formula: C26H28F3N3O4
M.Wt: 503.5134
Purity: >98%
Sotrage: 4°C for 1 year, -20°C for more than 2 years
Description: Glucagon receptor antagonists-4 is a highly potent glucagon receptor antagonist. It displays low in vivo clearance and excellent oral bioavailability in both rats and dogs.
References: [1]. Guzman-Perez A et al. The design and synthesis of a potent glucagon receptor antagonist with favorable physicochemical andpharmacokinetic properties as a candidate for the treatment of type 2 diabetes mellitus. Bioorg Med Chem Lett, 2013 May 15, 23(10):3051-8. [2]. Esther C.Y. Lee et al. Identification of a novel conformationally constrained glucagon receptor antagonist. Bioorg Med Chem Lett, 2014 Feb 1, 24(3):839-44.
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
2018-0101
Cat. No. Product name Field of application
DC9299 GRA Ex-25 GRA Ex-25 is an orally active human glucagon receptor antagonist in a transgenic murine pharmacodynamic model at 10 and 30 mpk.
DC10003 PF-06291874(glucagon receptor antagonists-4) glucagon receptor antagonists-4 is a highly potent glucagon receptor antagonist.
X